Cargando…
Prospective study on outcome of MDR-TB using the shorter regimen during COVID-19 pandemic
BACKGROUND: According to Indian TB report 2020, 66,225 MDR/RR-TB cases were detected in India, 56,569 (85%) were put on treatment, and 40,397 (75%) were initiated on shorter drug regimens at the time of diagnosis. In the absence of an effective vaccine, there is an urgent need for new treatment regi...
Autores principales: | Kumar, G Sravan, Sameena, P, Karthik, V, Ghanate, Nalini |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10451567/ https://www.ncbi.nlm.nih.gov/pubmed/37636185 http://dx.doi.org/10.4103/jfmpc.jfmpc_1723_22 |
Ejemplares similares
-
Limited Scope of Shorter Drug Regimen for MDR TB Caused by High Resistance to Fluoroquinolone
por: Singh, Pravin K., et al.
Publicado: (2019) -
Better programmatic outcome with the shorter regimen for the treatment of multidrug-resistant tuberculosis (MDR-TB) in Guinea: A retrospective cohort study
por: Hassane-Harouna, Souleymane, et al.
Publicado: (2020) -
Factors associated with treatment outcome of MDR/RR-TB patients treated with shorter injectable based regimen in West Java Indonesia
por: Soeroto, Arto Yuwono, et al.
Publicado: (2022) -
Shorter TB treatment regimens should be safer as well
por: Rucsineanu, O., et al.
Publicado: (2023) -
Cost of digital technologies and family-observed DOT for a shorter MDR-TB regimen: a modelling study in Ethiopia, India and Uganda
por: Rosu, Laura, et al.
Publicado: (2023)